Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Expression of CYP1A1, CYP1B1 and IL-1β in PBMCs and skin samples of PCB exposed individuals.

Leijs MM, Esser A, Amann PM, Schettgen T, Heise R, Fietkau K, Gube M, Merk HF, Kraus T, Baron JM.

Sci Total Environ. 2018 Nov 15;642:1429-1438. doi: 10.1016/j.scitotenv.2018.06.136. Epub 2018 Jun 22.

PMID:
30045523
2.

Surgical Site Infections After Dermatologic Surgery in Immunocompromised Patients: A Single-Center Experience.

Balakirski G, Kotliar K, Pauly KJ, Krings LK, Rübben A, Baron JM, Schmitt L.

Dermatol Surg. 2018 Jul 17. doi: 10.1097/DSS.0000000000001615. [Epub ahead of print]

PMID:
30045108
3.

Case 22-2018: A 64-Year-Old Man with Progressive Leg Weakness, Recurrent Falls, and Anemia.

Bennett SE, Schmitt WP, Stanford FC, Baron JM.

N Engl J Med. 2018 Jul 19;379(3):282-289. doi: 10.1056/NEJMcpc1802826. No abstract available.

PMID:
30021092
4.

Creation and Use of an Electronic Health Record Reporting Database to Improve a Laboratory Test Utilization Program.

Kurant DE, Baron JM, Strazimiri G, Lewandrowski KB, Rudolf JW, Dighe AS.

Appl Clin Inform. 2018 Jul;9(3):519-527. doi: 10.1055/s-0038-1666843. Epub 2018 Jul 11.

PMID:
29998456
5.

Effects of a ceramide-containing water-in-oil ointment on skin barrier function and allergen penetration in an IL-31 treated 3D model of the disrupted skin barrier.

Huth S, Schmitt L, Marquardt Y, Heise R, Lüscher B, Amann PM, Baron JM.

Exp Dermatol. 2018 May 31. doi: 10.1111/exd.13697. [Epub ahead of print]

PMID:
29851147
6.

Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience.

Thinnes A, Merk HF, Wurpts G, Röseler S, Lehmann S, Tenbrock K, Baron JM, Balakirski G.

Cutan Ocul Toxicol. 2018 Mar 22:1-10. doi: 10.1080/15569527.2018.1448990. [Epub ahead of print]

PMID:
29508626
7.

Hyperpigmentation and higher incidence of cutaneous malignancies in moderate-high PCB- and dioxin exposed individuals.

Leijs MM, Esser A, Amann PM, Schettgen T, Gube M, Merk HF, Kraus T, Baron JM.

Environ Res. 2018 Jul;164:221-228. doi: 10.1016/j.envres.2018.02.002. Epub 2018 Mar 20.

PMID:
29501832
8.

RIS-1/psoriasin expression in epithelial skin cells indicates their selective role in innate immunity and in inflammatory skin diseases including acne.

Zouboulis CC, Beutler C, Merk HF, Baron JM.

Dermatoendocrinol. 2017 Oct 4;9(1):e1338993. doi: 10.1080/19381980.2017.1338993. eCollection 2017.

9.

CYLD mutations differentially affect splicing and mRNA decay in Brooke-Spiegler syndrome.

Parren LJMT, Baron JM, Joussen S, Marquardt Y, Hanneken S, van Steensel MAM, Steijlen PM, van Geel M, Frank J.

J Eur Acad Dermatol Venereol. 2018 Feb 25. doi: 10.1111/jdv.14889. [Epub ahead of print] No abstract available.

PMID:
29478249
10.

Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.

Baron BW, Thirman MJ, Giurcanu MC, Baron JM.

Acta Haematol. 2018;139(2):132-139. doi: 10.1159/000486361. Epub 2018 Feb 14.

PMID:
29444501
11.

Direct biological effects of fractional ultrapulsed CO2 laser irradiation on keratinocytes and fibroblasts in human organotypic full-thickness 3D skin models.

Schmitt L, Huth S, Amann PM, Marquardt Y, Heise R, Fietkau K, Huth L, Steiner T, Hölzle F, Baron JM.

Lasers Med Sci. 2018 May;33(4):765-772. doi: 10.1007/s10103-017-2409-1. Epub 2017 Dec 7.

PMID:
29218493
12.

3D-MICE: integration of cross-sectional and longitudinal imputation for multi-analyte longitudinal clinical data.

Luo Y, Szolovits P, Dighe AS, Baron JM.

J Am Med Inform Assoc. 2018 Jun 1;25(6):645-653. doi: 10.1093/jamia/ocx133.

PMID:
29202205
13.

The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.

Pfaff CM, Marquardt Y, Fietkau K, Baron JM, Lüscher B.

Sci Rep. 2017 Nov 15;7(1):15631. doi: 10.1038/s41598-017-15892-7.

14.

Reticulocytes Are an Enriched Source of the RUVBL1 Protein.

Baron BW, Baron RM, Baron JM.

Acta Haematol. 2017;138(3):162-165. doi: 10.1159/000480449. Epub 2017 Oct 6. No abstract available.

PMID:
28982102
15.

Analysis of Daily Laboratory Orders at a Large Urban Academic Center: A Multifaceted Approach to Changing Test Ordering Patterns.

Rudolf JW, Dighe AS, Coley CM, Kamis IK, Wertheim BM, Wright DE, Lewandrowski KB, Baron JM.

Am J Clin Pathol. 2017 Aug 1;148(2):128-135. doi: 10.1093/ajcp/aqx054.

PMID:
28898984
16.

Case 3-2017: A Man with Cardiac Sarcoidosis and New Diplopia and Weakness.

Baron JM, Dighe AS, Flood JG.

N Engl J Med. 2017 May 11;376(19):1897. doi: 10.1056/NEJMc1702199. No abstract available.

17.

Utilization Management of High-Cost Imaging in an Outpatient Setting in a Large Stable Patient and Provider Cohort over 7 Years.

Weilburg JB, Sistrom CL, Rosenthal DI, Stout MB, Dreyer KJ, Rockett HR, Baron JM, Ferris TG, Thrall JH.

Radiology. 2017 Sep;284(3):766-776. doi: 10.1148/radiol.2017160968. Epub 2017 Apr 21.

PMID:
28430557
18.

Molecular effects of fractional ablative erbium:YAG laser treatment with multiple stacked pulses on standardized human three-dimensional organotypic skin models.

Schmitt L, Amann PM, Marquardt Y, Heise R, Czaja K, Gerber PA, Steiner T, Hölzle F, Baron JM.

Lasers Med Sci. 2017 May;32(4):805-814. doi: 10.1007/s10103-017-2175-0. Epub 2017 Mar 15.

PMID:
28299490
19.

Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.

Ainscough JS, Macleod T, McGonagle D, Brakefield R, Baron JM, Alase A, Wittmann M, Stacey M.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2748-E2757. doi: 10.1073/pnas.1620954114. Epub 2017 Mar 13.

20.

Effectiveness and Safety of Surgical Excision in the Treatment of Digital Mucoid Cysts.

Balakirski G, Loeser C, Baron JM, Dippel E, Schmitt L.

Dermatol Surg. 2017 Jul;43(7):928-933. doi: 10.1097/DSS.0000000000001096.

PMID:
28272086
21.

Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.

Steinkamp AD, Schmitt L, Chen X, Fietkau K, Heise R, Baron JM, Bolm C.

Skin Pharmacol Physiol. 2016;29(6):281-290. doi: 10.1159/000453042. Epub 2016 Dec 24.

22.

Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.

Brocks T, Fedorchenko O, Schliermann N, Stein A, Moll UM, Seegobin S, Dewor M, Hallek M, Marquardt Y, Fietkau K, Heise R, Huth S, Pfister H, Bernhagen J, Bucala R, Baron JM, Fingerle-Rowson G.

FASEB J. 2017 Feb;31(2):526-543. doi: 10.1096/fj.201600860R. Epub 2016 Oct 19.

PMID:
27825106
23.

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 24-2016. A 66-Year-Old Man with Malaise, Weakness, and Hypercalcemia.

Bazari H, Palmer WE, Baron JM, Armstrong K.

N Engl J Med. 2016 Aug 11;375(6):567-74. doi: 10.1056/NEJMcpc1503829. No abstract available.

PMID:
27509105
24.

Health Care Infrastructure for Financially Sustainable Clinical Genomics.

Lennerz JK, McLaughlin HM, Baron JM, Rasmussen D, Sumbada Shin M, Berners-Lee N, Miller Batten J, Swoboda KJ, Gala MK, Winter HS, Schmahmann JD, Sweetser DA, Boswell M, Pacula M, Stenzinger A, Le LP, Hynes W, Rehm HL, Klibanski A, Black-Schaffer SW, Golden JA, Louis DN, Weiss ST, Iafrate AJ.

J Mol Diagn. 2016 Sep;18(5):697-706. doi: 10.1016/j.jmoldx.2016.04.003. Epub 2016 Jul 25.

25.

Using Machine Learning to Predict Laboratory Test Results.

Luo Y, Szolovits P, Dighe AS, Baron JM.

Am J Clin Pathol. 2016 Jun;145(6):778-88. doi: 10.1093/ajcp/aqw064. Epub 2016 Jun 21.

PMID:
27329638
26.

Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model.

Huth S, Marquardt Y, Amann PM, Leverkus M, Huth L, Baron JM, Gerber PA.

Exp Dermatol. 2016 Dec;25(12):997-999. doi: 10.1111/exd.13068. Epub 2016 Oct 3. No abstract available.

PMID:
27194644
27.

Perceptions of pathology informatics by non-informaticist pathologists and trainees.

Walker A, Garcia C, Baron JM, Gudewicz TM, Gilbertson JR, Henricks WH, Lee RE.

J Pathol Inform. 2016 Apr 11;7:14. doi: 10.4103/2153-3539.179904. eCollection 2016.

28.

Nachruf.

Bröcker E, Gollnick H, Goerdt S, Baron JM.

J Dtsch Dermatol Ges. 2016 May;14(5):459-61. doi: 10.1111/ddg.13015. No abstract available.

PMID:
27119464
29.

Benign chronic immune thrombocytopenic purpura in adult males.

Baron BW, Baron JM.

Am J Hematol. 2016 Jul;91(7):E321-2. doi: 10.1002/ajh.24387. Epub 2016 May 11. No abstract available.

30.
31.

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia.

Falchi L, Baron JM, Orlikowski CA, Ferrajoli A.

Mediterr J Hematol Infect Dis. 2016 Feb 10;8(1):e2016011. doi: 10.4084/MJHID.2016.011. eCollection 2016. Review.

32.

Control of the Physical and Antimicrobial Skin Barrier by an IL-31-IL-1 Signaling Network.

Hänel KH, Pfaff CM, Cornelissen C, Amann PM, Marquardt Y, Czaja K, Kim A, Lüscher B, Baron JM.

J Immunol. 2016 Apr 15;196(8):3233-44. doi: 10.4049/jimmunol.1402943. Epub 2016 Mar 4.

33.

Potential health risk of allergenic pollen with climate change associated spreading capacity: Ragweed and olive sensitization in two German federal states.

Höflich C, Balakirski G, Hajdu Z, Baron JM, Kaiser L, Czaja K, Merk HF, Gerdsen S, Strassen U, Bas M, Bier H, Dott W, Mücke HG, Straff W, Chaker A, Röseler S.

Int J Hyg Environ Health. 2016 May;219(3):252-60. doi: 10.1016/j.ijheh.2016.01.007. Epub 2016 Feb 1.

34.

ST2 Predicts Mortality and Length of Stay in a Critically Ill Noncardiac Intensive Care Unit Population.

Rudolf JW, Lewandrowski EL, Lewandrowski KB, Januzzi JL, Bajwa EK, Baron JM.

Am J Clin Pathol. 2016 Feb;145(2):203-10. doi: 10.1093/ajcp/aqv082. Epub 2016 Feb 8.

PMID:
26857195
35.

Effects of non-ablative fractional erbium glass laser treatment on gene regulation in human three-dimensional skin models.

Amann PM, Marquardt Y, Steiner T, Hölzle F, Skazik-Voogt C, Heise R, Baron JM.

Lasers Med Sci. 2016 Apr;31(3):397-404. doi: 10.1007/s10103-015-1863-x. Epub 2016 Jan 21.

PMID:
26796701
36.

Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.

Heise R, Amann PM, Ensslen S, Marquardt Y, Czaja K, Joussen S, Beer D, Abele R, Plewnia G, Tampé R, Merk HF, Hermanns HM, Baron JM.

PLoS One. 2016 Jan 6;11(1):e0146325. doi: 10.1371/journal.pone.0146325. eCollection 2016.

37.

Myeloid human cell lines lack functional regulation of aryl hydrocarbon receptor-dependent phase I genes.

Skazik-Voogt C, Kühler K, Ott H, Czaja K, Zwadlo-Klarwasser G, Merk HF, Amann PM, Baron JM.

ALTEX. 2016;33(1):37-46. doi: 10.14573/altex.1502041. Epub 2015 Nov 19.

38.

Stand-alone interspinous spacer versus decompressive laminectomy for treatment of lumbar spinal stenosis.

Lauryssen C, Jackson RJ, Baron JM, Tallarico RA, Lavelle WF, Deutsch H, Block JE, Geisler FH.

Expert Rev Med Devices. 2015;12(6):763-9. doi: 10.1586/17434440.2015.1100071. Epub 2015 Oct 21.

PMID:
26487285
39.

Environmental components and methods for engaging pathology residents in informatics training.

Garcia CA, Baron JM, Beckwith BA, Brodsky V, Dighe AS, Gudewicz TM, Kim JY, Klepeis VE, Lane WJ, Lee RE, Levy BP, Mahowald MA, Mandelker D, McClintock DS, Quinn AM, Rao LK, Riedlinger GM, Rudolf J, Gilbertson JR.

J Pathol Inform. 2015 Jun 29;6:42. eCollection 2015. No abstract available.

40.

Applying Lean methodologies reduces ED laboratory turnaround times.

White BA, Baron JM, Dighe AS, Camargo CA Jr, Brown DF.

Am J Emerg Med. 2015 Nov;33(11):1572-6. doi: 10.1016/j.ajem.2015.06.013. Epub 2015 Jun 14.

41.

Retinoid treatment of skin diseases.

Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM.

Eur J Dermatol. 2015 Sep-Oct;25(5):384-91. doi: 10.1684/ejd.2015.2544. Review.

PMID:
26069148
42.

[Prof. Dr. Hans Merk on the occasion of his 65th birthday].

Hertl M, Baron JM.

Hautarzt. 2015 Apr;66(4):303-4. doi: 10.1007/s00105-015-3625-x. German. No abstract available.

PMID:
25809460
43.

Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.

Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM.

Exp Dermatol. 2015 Sep;24(9):663-8. doi: 10.1111/exd.12704. Epub 2015 Apr 17.

PMID:
25809190
44.

Clinical laboratory analytics: Challenges and promise for an emerging discipline.

Shirts BH, Jackson BR, Baird GS, Baron JM, Clements B, Grisson R, Hauser RG, Taylor JR, Terrazas E, Brimhall B.

J Pathol Inform. 2015 Feb 24;6:9. doi: 10.4103/2153-3539.151919. eCollection 2015.

45.

Characterization of a novel standardized human three-dimensional skin wound healing model using non-sequential fractional ultrapulsed CO2 laser treatments.

Marquardt Y, Amann PM, Heise R, Czaja K, Steiner T, Merk HF, Skazik-Voogt C, Baron JM.

Lasers Surg Med. 2015 Mar;47(3):257-65. doi: 10.1002/lsm.22341. Epub 2015 Mar 15.

PMID:
25771913
46.

LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid antitumor efficacy in the murine melanoma B16F10 cell line.

Amann PM, Czaja K, Bazhin AV, Rühl R, Eichmüller SB, Merk HF, Baron JM.

Skin Pharmacol Physiol. 2015;28(4):205-12.

PMID:
25721651
47.

Case records of the Massachusetts General Hospital. Case 4-2015. A 49-year-old man with obtundation followed by agitation and acidosis.

Cooper CM, Baron JM.

N Engl J Med. 2015 Jan 29;372(5):465-73. doi: 10.1056/NEJMcpc1410940. No abstract available.

PMID:
25629745
48.

The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Baron BW, Baron RM, Baron JM.

Biochim Biophys Acta. 2015 May;1852(5):742-8. doi: 10.1016/j.bbadis.2014.12.018. Epub 2014 Dec 31.

49.

Enhanced creatinine and estimated glomerular filtration rate reporting to facilitate detection of acute kidney injury.

Baron JM, Cheng XS, Bazari H, Bhan I, Lofgren C, Jaromin RT, Lewandrowski KB, Dighe AS.

Am J Clin Pathol. 2015 Jan;143(1):42-9. doi: 10.1309/AJCP05XBCQPHTLGQ.

PMID:
25511141
50.

[Double sensitization to PR10 and PR-14 proteins].

Vanstreels L, Balakirski G, Röseler S, Wurpts G, Megahed M, Baron JM, Merk HF.

Hautarzt. 2014 Dec;65(12):1017-8. doi: 10.1007/s00105-014-3540-6. German.

PMID:
25376621

Supplemental Content

Loading ...
Support Center